Bioventus Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Bioventus Inc. now
Current reporting with the operating signal separated from the noise.
Bioventus Inc. (BVS) Q1 2026 Earnings Call Transcript
Investors are testing whether Bioventus Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Bioventus Inc. (BVS)
The story matters when it changes Bioventus Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Investors are testing whether Bioventus Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Bioventus Inc. (BVS) Q1 2023 Earnings Call Transcript
Investors are testing whether Bioventus Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance
The story matters when it changes Bioventus Inc.’s customers, execution, competitive position or capital requirements.
Watch next: official volume, pricing, inventory and segment margin.Latest BVS filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Bioventus Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →